MCID: PTY001
MIFTS: 42

Pityriasis Rosea malady

Category: Skin diseases

Aliases & Classifications for Pityriasis Rosea

About this section

Aliases & Descriptions for Pityriasis Rosea:

Name: Pityriasis Rosea 11 39 13 68
 
Pityriasis Circinata 11

Classifications:



External Ids:

Disease Ontology11 DOID:8892
ICD1030 L42
ICD9CM32 696.3
SNOMED-CT62 156373006, 77252004
MeSH39 D017515
NCIt45 C26855

Summaries for Pityriasis Rosea

About this section
Wikipedia:71 Pityriasis rosea (also known as pityriasis rosea Gibert) is a skin rash. It is benign but may inflict... more...

MalaCards based summary: Pityriasis Rosea, also known as pityriasis circinata, is related to hepatitis and pityriasis rotunda. An important gene associated with Pityriasis Rosea is HLA-C (Major Histocompatibility Complex, Class I, C), and among its related pathways are Viral carcinogenesis and Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell. The drugs methdilazine and methdilazine hydrochloride have been mentioned in the context of this disorder. Affiliated tissues include skin, t cells and tongue, and related mouse phenotype Increased shRNA abundance (Z-score > 2).

Related Diseases for Pityriasis Rosea

About this section

Diseases related to Pityriasis Rosea via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 121)
idRelated DiseaseScoreTop Affiliating Genes
1hepatitis29.9HLA-A, HLA-B, HLA-C, HLA-DRB1
2pityriasis rotunda11.4
3psoriasis10.2
4mirizzi syndrome10.2HLA-B, HLA-DRB1
5kernicterus due to isoimmunization10.2HLA-C, HLA-DRB1
6swine influenza10.2HLA-B, HLA-DRB1
7solid pseudopapillary carcinoma of pancreas10.2HLA-A, HLA-B
8myopathy, congenital nonprogressive, with moebius sequence and robin sequence10.2HLA-A, HLA-B
9dermatitis10.2
10pseudohypoparathyroidism10.2HLA-C, HLA-DRB1
11aortic coarctation10.1HLA-A, HLA-B
12bubonic plague10.1HLA-A, HLA-B
13epstein-barr virus, susceptibility to chronic infection by10.1HLA-A, HLA-C
14gonococcal endophthalmia10.1HLA-A, HLA-B
15apple allergy10.1HLA-DQB1, HLA-DRB1
16hemoglobin d disease10.1HLA-DQB1, HLA-DRB1
17cerebral sarcoidosis10.1HLA-A, HLA-DRB1
18bilateral parasagittal parieto-occipital polymicrogyria10.1HLA-DQB1, HLA-DRB1
19lin-gettig syndrome10.1HLA-DQB1, HLA-DRB1
20midline interhemispheric variant of holoprosencephaly10.1HLA-DQB1, HLA-DRB1
21mastitis10.1HLA-A, HLA-B
22autosomal dominant intermediate charcot-marie-tooth10.1HLA-DQB1, HLA-DRB1
23renal agenesis meningomyelocele mullerian defect10.1HLA-DQB1, HLA-DRB1
24lyme disease - neurological complications10.1HLA-DQB1, HLA-DRB1
25distal trisomy 14q10.1HLA-DQB1, HLA-DRB1
26linear lichen planus10.1HLA-DQB1, HLA-DRB1
27myeloid and lymphoid neoplasms with eosinophilia and abnormalities of pdgfra, pdgfrb, and fgfr110.1HLA-B, HLA-DQB1
28night blindness10.1HLA-DQB1, HLA-DRB1
29motility-related diarrhea10.1HLA-A, HLA-DRB1
30neonatal antiphospholipid syndrome10.1HLA-DQB1, HLA-DRB1
31rete testis adenocarcinoma10.1HLA-A, HLA-DQB1
32disease of mental health10.1HLA-B, HLA-DRB1
33urethral gland abscess10.1HLA-C, HLA-DRB1
34plummer's disease10.1HLA-DRB1, HLA-DRB5
35lichen planus10.1
36clostridium difficile colitis10.1HLA-DQB1, HLA-DRB1
37myofibroma10.1HLA-DQB1, HLA-DRB1
38central nervous system lymphoma10.1HLA-A, HLA-B
39oromandibular dystonia10.1HLA-DQB1, HLA-DRB1
40patau syndrome10.1HLA-A, HLA-DRB1
41acute cholangitis10.1HLA-B, HLA-C, HLA-DRB1
42molybdenum cofactor deficiency a10.1HLA-B, HLA-C, HLA-DRB1
43epididymo-orchitis10.0HLA-A, HLA-B, HLA-C
44colorectal cancer, hereditary nonpolyposis, type 610.0HLA-A, HLA-B, HLA-C
45low anorectal malformation10.0HLA-DQB1, HLA-DRB1
46hashimoto's encephalitis10.0HLA-DRB1, HLA-DRB4
47orbital osteomyelitis10.0HLA-A, HLA-B, HLA-C
48autosomal recessive congenital methemoglobinemia10.0HLA-A, HLA-B, HLA-C
49psoriasis susceptibility 110.0HLA-A, HLA-B, HLA-C
50ragweed sensitivity10.0HLA-DQB1, HLA-DRB1

Graphical network of the top 20 diseases related to Pityriasis Rosea:



Diseases related to pityriasis rosea

Symptoms & Phenotypes for Pityriasis Rosea

About this section

GenomeRNAi Phenotypes related to Pityriasis Rosea according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00366-A-192-2.6HLA-A, HLA-B, HLA-C, HLA-DRB4, HLA-A, HLA-B

Drugs & Therapeutics for Pityriasis Rosea

About this section

Drugs for Pityriasis Rosea (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
PetrolatumapprovedPhase 4938009-03-8
Synonyms:
Multi-hydrocarbon
Paraffinum album
Paraffinum flavum
Petrolatum base
Petrolatum, white
 
Petrolatum,amber
Petrolatum,white
Petroleum jelly
Soft paraffin
White petrolatum
White, soft paraffin
Yellow soft paraffin
2
Tacrolimusapproved, investigationalPhase 41102104987-11-3445643, 439492
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
Anhydrous tacrolimus
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
 
FR900506
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus anhydrous
Tacrolimus hydrate
Tacrolimus, anhydrous
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
3
Calcitriolapproved, nutraceuticalPhase 421032222-06-3134070, 5280453
Synonyms:
(1R,3S)-5-{2-[(1R,3aS,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10-triene-1,3,25-triol
(1alpha,3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(1α,3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol
(5Z,7E)-(1S,3R)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1-alpha,3-beta,25-triol
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta,25-triol
1 alpha,25-Dihydroxyvitamin D3
1,25 (OH)2 D3
1,25 Dihydroxycholecalciferol
1,25(OH)2-20epi-D3
1,25(OH)2D3 & CD4
1,25(OH2)D3
1,25-(OH)2-D3
1,25-(OH)2D3
1,25-DHCC
1,25-DIHYDROXYCHOLECALCIFEROL
1,25-Dihydroxycholecalciferol
1,25-Dihydroxycholecaliferol
1,25-Dihydroxyvitamin D
1,25-Dihydroxyvitamin D3
1,25-dihydroxy vitamin D3
1,25-dihydroxy-20-epi-Vitamin D3
1,25-dihydroxycholecalciferol
1,25D3
1-alpha,-1,25-Dihydroxyvitamin D3
1-alpha,25-Dihydroxycholecalciferol
1-alpha,25-Dihydroxyvitamin D3
1-alpha-25-Dihydroxyvitamin D3
1-alpha-25-dihydroxyvitamin D3
1.Alpha.,25-Dihydroxy-26,27-hexadeuterovitamin D3
17936_FLUKA
17936_SIGMA
1a,25-(OH)2D3
1a,25-Dihydroxycholecalciferol
1a,25-Dihydroxyvitamin D3
1alpha,25(OH)2-D3
1alpha,25(OH)2D3
1alpha,25-Dihydroxycholecalciferol
1alpha,25-Dihydroxyvitamin D
1alpha,25-Dihydroxyvitamin D3
1db1
1α,25(OH)2D3
1α,25-dihydroxycholecalciferol
1α,25-dihydroxyvitamin D3
20-epi-1alpha,25-dihydroxycholecaliferol
25-Dihydroxycholecalciferol
32222-06-3
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha,3beta,25-triol
9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta,.5Z,7E)- & CD4
9,10-seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha, 3beta, 25-triol
AC-1859
AC1NQX1S
Ambap32222-06-3
 
Asentar
BCBcMAP01_000160
BML2-E03
BSPBio_001287
C01673
CCRIS 5522
CD-2027
CHEBI:17823
CHEMBL846
CID5280453
CPD000466393
Calcijex
Calcijex, Silkis, Rocaltrol, Topitriol, Cholecalciferol,Calcitriol
Calcitriol
Calcitriol (JAN/USAN/INN)
Calcitriol [USAN:INN:BAN:JAN]
Calcitriolum
Calcitriolum [INN-Latin]
D00129
D1530_SIGMA
DN 101
DN-101
Decostriol
Dihydroxyvitamin D3
EINECS 250-963-8
HMS1361A09
HMS1791A09
HMS1989A09
HMS2051F06
HMS2089N03
HSDB 3482
IDI1_033757
LMST03020258
LS-53093
MC-1288
MC1288
MLS000759536
MLS001424122
MolPort-002-045-698
NCGC00161327-01
NCGC00161327-04
Ro 21-5535
Ro 215535
Ro-21-5535
Rocaltrol
Rocaltrol (TN)
S1466_Selleck
SAM001246772
SMR000466393
Silkis
Soltriol
Spectrum5_002061
Topitriol
Toptriol
U 49562
Vectical
ZINC03924790
calcitriol
vit D
4Trace ElementsPhase 46001
5vitamin dPhase 41724
6VitaminsPhase 45282
7Vasoconstrictor AgentsPhase 42122
8Immunosuppressive AgentsPhase 413086
9Calcium, DietaryPhase 45713
10Calcineurin InhibitorsPhase 41622
11Dermatologic AgentsPhase 45806
12EmollientsPhase 4155
13Bone Density Conservation AgentsPhase 43376
14MicronutrientsPhase 46001

Interventional clinical trials:

idNameStatusNCT IDPhase
1Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis AlbaCompletedNCT01388517Phase 4

Search NIH Clinical Center for Pityriasis Rosea

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: pityriasis rosea

Genetic Tests for Pityriasis Rosea

About this section

Anatomical Context for Pityriasis Rosea

About this section

MalaCards organs/tissues related to Pityriasis Rosea:

36
Skin, T cells, Tongue, Myeloid, Testes, Bone, Bone marrow

Publications for Pityriasis Rosea

About this section

Articles related to Pityriasis Rosea:

(show top 50)    (show all 403)
idTitleAuthorsYear
1
The role of interleukin-22 in pityriasis rosea. (27862158)
2017
2
Diagnosis and management of pityriasis rosea. (28002142)
2017
3
Atypical pityriasis rosea presenting with a herald patch lesion on the healed site of herpes zoster: Wolf's isotopic response. (26678150)
2016
4
A position statement on the management of patients with pityriasis rosea. (27406919)
2016
5
Pityriasis rosea along Blaschko's lines: A rare variant. (27852994)
2016
6
Pityriasis rosea: a natural history of pediatric cases in theCentral Anatolia Region of Turkey. (28081320)
2016
7
Atypical pityriasis rosea: clinical evaluation of 27 patients. (27558764)
2016
8
Pityriasis rosea in pregnancy: report of a spousal occurrence and craniosynostosis in the healthy newborn. (27648382)
2016
9
Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies? (27103975)
2016
10
Pityriasis Rosea: A Comprehensive Classification. (27096928)
2016
11
Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects. (27512182)
2016
12
Salute sign: A nonambiguous histopathological sign in pityriasis rosea. (27990399)
2016
13
Red Cell Distribution Width and Mean Platelet Volume in Patients With Pityriasis Rosea. (27222672)
2016
14
Is a treatment for pityriasis rosea really needed? (27730050)
2016
15
The Oxidant and Antioxidant Status in Pityriasis Rosea. (26955119)
2016
16
A Herald Patch Almost Encircling the Trunk-Extreme Pityriasis Rosea Gigantea in a Young Child. (27396667)
2016
17
A case series of erythema multiforme-like pityriasis rosea. (27294066)
2016
18
Anesthetic Considerations for Neuraxial Anesthesia in Pregnant Patients With Pityriasis Rosea With Skin Lesions Covering the Lumbar Spine. (27513966)
2016
19
Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial. (27212277)
2016
20
Pityriasis rosea-like adverse reaction to atenolol. (25791321)
2015
21
Narrowband UVB phototherapy in pityriasis rosea. (26500862)
2015
22
Pityriasis rosea. (26514823)
2015
23
Acyclovir in pityriasis rosea: An observer-blind, randomized controlled trial of effectiveness, safety and tolerability. (26009712)
2015
24
Pigmentogenes Pityriasis Rosea. (26584426)
2015
25
Pityriasis Rosea in Children: Clinical Features and Laboratory Investigations. (25997658)
2015
26
The Role of Cytokines, Chemokines, and Growth Factors in the Pathogenesis of Pityriasis Rosea. (26451078)
2015
27
Segmental pityriasis rosea within the area of BRAF-mutated metastatic melanoma. (26446380)
2015
28
Terbinafine induced pityriasis rosea-like eruption. (26729964)
2015
29
Pityriasis rosea-like cutaneous eruption as the presenting symptom of Hodgkin lymphoma. Case report and review of the literature. (26512305)
2015
30
The diagnostic criteria of pityriasis rosea and Gianotti-Crosti syndrome - a protocol to establish diagnostic criteria of skin diseases. (26517103)
2015
31
The efficacy of macrolides and acyclovir in pityriasis rosea. (25566900)
2015
32
Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection. (25612842)
2015
33
Author's Response--The efficacy of azithromycin in pityriasis rosea: a randomized, double-blind, placebo-controlled trial. (25566901)
2015
34
Nomenclature of drug-induced pityriasis rosea-like rashes. (26491333)
2015
35
Pityriasis rosea following human papillomavirus vaccination. (25527111)
2015
36
Facial involvement in Pityriasis Rosea. (26584310)
2015
37
An atypical case of pityriasis rosea gigantea after influenza vaccination. (24847250)
2014
38
The prevalence of herpes zoster and pityriasis rosea in patients with psoriasis: a preliminary study. (25353629)
2014
39
A Randomized, Double-blind, Placebo-Controlled Study of Efficacy of Oral Acyclovir in the Treatment of Pityriasis Rosea. (24995231)
2014
40
Multiple recurrences in pityriasis rosea - a case report with review of the literature. (24891682)
2014
41
Efficacy of clarithromycin in pityriasis rosea. (25404436)
2014
42
Pityriasis rosea like drug rash - a need to identify the disease in childhood. (25302254)
2014
43
Pityriasis rosea-like arranged eruption after infliximab therapy in a patient with psoriasis vulgaris. (24617533)
2014
44
The saliva quantitative PCR assay is inadequate to detect and monitor human herpesvirus-7 and -6 reactivation in patients with Pityriasis rosea. (25453575)
2014
45
Decreased Serum Level of Interferon-I^ in Patients with Pityriasis Rosea. (25143687)
2014
46
Pityriasis rosea and pityriasis rosea-like eruptions. (24355268)
2014
47
Unilateral pityriasis rosea. (25396152)
2014
48
Pityriasis rosea and activation of latent herpesvirus infections. (24355270)
2014
49
Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature. (25545307)
2014
50
Localized purpuric lesions in a case of classical pityriasis rosea. (25382521)
2014

Variations for Pityriasis Rosea

About this section

Expression for genes affiliated with Pityriasis Rosea

About this section
Search GEO for disease gene expression data for Pityriasis Rosea.

Pathways for genes affiliated with Pityriasis Rosea

About this section

Pathways related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 34)
idSuper pathwaysScoreTop Affiliating Genes
19.2HLA-A, HLA-B, HLA-C
29.2HLA-A, HLA-B, HLA-C
39.2HLA-A, HLA-B, HLA-C
4
Show member pathways
9.2HLA-A, HLA-B, HLA-C
5
Show member pathways
9.2HLA-A, HLA-B, HLA-C
6
Show member pathways
9.2HLA-A, HLA-B, HLA-C
79.2HLA-A, HLA-B, HLA-C
8
Show member pathways
8.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
9
Show member pathways
8.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
108.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
11
Show member pathways
8.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
12
Show member pathways
8.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
13
Show member pathways
8.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
14
Show member pathways
8.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
15
Show member pathways
8.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
16
Show member pathways
8.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
17
Show member pathways
8.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
188.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
198.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
208.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
218.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
228.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
23
Show member pathways
8.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
24
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
256.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
266.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
27
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
286.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
29
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
30
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
31
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
326.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
33
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
34
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4

GO Terms for genes affiliated with Pityriasis Rosea

About this section

Cellular components related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 19)
idNameGO IDScoreTop Affiliating Genes
1early endosome membraneGO:003190110.0HLA-A, HLA-B, HLA-C
2MHC class I protein complexGO:004261210.0HLA-A, HLA-B, HLA-C
3phagocytic vesicle membraneGO:003067010.0HLA-A, HLA-B, HLA-C
4recycling endosome membraneGO:00550389.7HLA-A, HLA-B, HLA-C
5endosome membraneGO:00100089.7HLA-DQB1, HLA-DRB1, HLA-DRB5
6cell surfaceGO:00099869.5HLA-A, HLA-B, HLA-C, HLA-DRB1
7late endosome membraneGO:00319029.5HLA-DRB1, HLA-DRB4, HLA-DRB5
8endoplasmic reticulumGO:00057839.0HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DRB5
9Golgi apparatusGO:00057949.0HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DRB5
10clathrin-coated endocytic vesicle membraneGO:00306698.9HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
11endocytic vesicle membraneGO:00306668.9HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
12lysosomal membraneGO:00057658.8HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
13MHC class II protein complexGO:00426138.8HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
14trans-Golgi network membraneGO:00325888.5HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
15transport vesicle membraneGO:00306588.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
16ER to Golgi transport vesicle membraneGO:00125077.6HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
17Golgi membraneGO:00001397.5HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
18integral component of lumenal side of endoplasmic reticulum membraneGO:00715567.5HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
19plasma membraneGO:00058867.3HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4

Biological processes related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 17)
idNameGO IDScoreTop Affiliating Genes
1protection from natural killer cell mediated cytotoxicityGO:004227010.2HLA-A, HLA-B
2humoral immune response mediated by circulating immunoglobulinGO:000245510.1HLA-DQB1, HLA-DRB1
3immunoglobulin production involved in immunoglobulin mediated immune responseGO:000238110.1HLA-DQB1, HLA-DRB1
4antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependentGO:00024799.9HLA-A, HLA-B, HLA-C
5antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independentGO:00024809.9HLA-A, HLA-B, HLA-C
6antigen processing and presentation of peptide antigen via MHC class IGO:00024749.9HLA-A, HLA-B, HLA-C
7regulation of immune responseGO:00507769.8HLA-A, HLA-B, HLA-C
8type I interferon signaling pathwayGO:00603379.8HLA-A, HLA-B, HLA-C
9antigen processing and presentation of peptide or polysaccharide antigen via MHC class IIGO:00025049.6HLA-DQB1, HLA-DRB1, HLA-DRB5
10immune system processGO:00023768.9HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DRB5
11antigen processing and presentation of exogenous peptide antigen via MHC class IIGO:00198868.8HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
12T cell costimulationGO:00312958.7HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
13viral processGO:00160328.7HLA-A, HLA-B, HLA-C, HLA-DRB1
14T cell receptor signaling pathwayGO:00508528.7HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
15antigen processing and presentationGO:00198828.3HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB5
16immune responseGO:00069558.3HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB5
17interferon-gamma-mediated signaling pathwayGO:00603337.4HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4

Molecular functions related to Pityriasis Rosea according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class II receptor activityGO:003239510.0HLA-DQB1, HLA-DRB1
2receptor bindingGO:00051029.2HLA-A, HLA-B, HLA-C
3peptide antigen bindingGO:00426058.2HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB5

Sources for Pityriasis Rosea

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet